Wei X, Ying M, Dehaini D, Su Y, Kroll AV, Zhou J, Gao W, Fang RH, Chien S, Zhang L
It is a single daily subcutaneous injection on a provider-determined schedule
The compounds demonstrated different pharmacology in vivo, with TLC-2716 having lower plasma exposures and higher and sustained ileum and liver exposures (due to active uptake into hepatocytes) than TLC-6665 (ratio of AUCs of TLC-2716/TLC-6665 in plasma and liver of 0.17 and 6.24, respectively
Horowitz, R
Thats because clinical studies arent extensive enough to confidently state its benefits
If you run your hand over your desk right now, I hate to break it to you buttheres mold